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Background: Aging is associated with a decline in lymphocyte function however, little is known about dendritic cell
(DC) subsets and aging. Aging is also associated with increasing circulating lipid levels and intracellular lipid
accumulation modulates DC function. Whether age-associated increases in lipid levels influence DC biology is unknown.
Thus, the effects of aging on DC subsets were assessed in vivo using young adult and elderly C57BL/6 J mice.
Results: Major age-related changes included increased CD11c+ DC numbers in lymph nodes, spleens and livers, but not
lungs, and significantly increased proportions of plasmacytoid (pDC) and CD4−CD8α+ DCs in lymph nodes and livers.
Other changes included altered pDC activation status (decreased CD40, increased MHC class-I and MHC class-II),
increased lipid content in pDCs and CD4−CD8α+ DCs, and increased expression of key mediators of lipid uptake
including lipoprotein lipase, scavenger receptors (CD36, CD68 and LRP-1) in most tissues.
Conclusions: Aging is associated with organ-specific numerical changes in DC subsets, and DC activation status, and
increased lipid content in pDCs and CD4−CD8α+ DCs. Up-regulation of lipoprotein lipase and scavenger receptors by
lipid-rich pDCs and CD4−CD8α+ DCs suggests these molecules contribute to DC lipid accumulation in the elderly. Lipid
accumulation and modulated activation in pDCs and CD4−CD8α+ DCs may contribute to the declining responses to
vaccination and infection with age.
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Aging is associated with a decline in immune function,
termed immunosenescence, which results in decreased
vaccine efficacy and increased incidence of infection,
cancer and autoimmunity [1-4]. This decrease in immune
competence has been attributed to age-related changes to
the numbers and function of T- and B-lymphocytes [2].
However, the role of antigen presenting cells (APCs), in
particular dendritic cells (DCs), in aging is becoming
apparent. DCs are professional APCs which initiate and
control immune responses against pathogenic antigens* Correspondence: Delia.Nelson@curtin.edu.au
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unless otherwise stated.(Ag) and facilitate tolerance toward self and harmless
environmental Ag [5]. In cancer and atherosclerosis,
pathologies associated with increased circulating lipid con-
centrations, DC lipid accumulation has been associated
with dysfunction [6].
Circulating lipid concentrations also significantly
increase with healthy aging [7]. Thus, tissue DCs in
otherwise healthy elderly hosts might be exposed to ele-
vated lipid levels leading to DC lipid accumulation. Aging
is associated with inflammaging, a low-grade, chronic, sys-
temic inflammatory state involving increased levels of cir-
culating pro-inflammatory cytokines such as interleukin-1
(IL-1), interleukin-6 (IL-6) and tumour necrosis factor
(TNF) [8] which may contribute to the increased preva-
lence of autoimmunity seen in the aged [1]. Lipid uptake
by DCs may lead to inappropriate DC activation such that
they secrete these pro-inflammatory factors and contributel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mediated DC dysfunction might contribute to the age-
related decline in immune function and that this might be
an early event that precedes the development of age-
related pathologies.
The exact mechanisms of lipid accumulation in DCs
are poorly understood. Previous studies on macrophages
have identified lipoprotein lipase (LPL) [9], scavenger
receptors [10-14] and the very low density lipoprotein
receptor (VLDLr) [15] as significant contributors to lipid
uptake, therefore DCs may use the same receptors to
take up lipids during aging. Changes to these receptors
on DCs during aging had not been examined.
Until now, no studies had investigated the influence of
age on DC subset distribution, their activation status,
lipid content or expression of molecular mediators of
lipid uptake in multiple tissues from healthy hosts.
Therefore, this study aimed firstly to determine if con-
ventional, plasmacytoid and cross-presenting DCs from
apparently healthy elderly mice acquire greater lipid
levels relative to younger mice despite being housed in the
same environment and being on the same diet. Secondly,
we aimed to identify possible mechanisms by which lipids
are taken up by elderly-derived DCs. We examined DC
lipid content and phenotype including molecules associ-
ated with antigen presentation and lipid uptake in second-
ary lymphoid organs, liver and lungs, from young adult
(equivalent to 18 to 20 human years) and elderly (equiva-
lent to 56 to 69 human years) mice [16,17].
Results
CD11c+ DC proportions increase in elderly murine tissues
Spleens, lymph nodes (LNs) from different sites, lungs and
livers from young and elderly mice were disaggregated
into single cell suspensions and stained for CD11c+ DCs
(Figure 1A). The percentage of total cells that wereFigure 1 CD11c+ dendritic cell proportions increase in elderly murine
suspensions and stained for CD11c+ DCs. CD11c+ DCs were identified and
percentages of cells positive for CD11c in tissues are shown in young and eld
and is pooled from 2 separate experiments, total n = 7 – 8 mice/group. * = pCD11c+ DCs increased in all elderly-derived tissues
(compared to young mice) except spleens and lungs, in
which CD11c+ DC proportions did not change. Significant
differences were seen in mesenteric (mes) LNs, superficial
cervical (sup) LNs and livers (Figure 1B). As total body
and organ weights increased with age (Additional file 1:
Figure S1A and S1B), CD11c+ DCs were also calculated as
DCs/mg of tissue; the data show that age-related changes
were maintained in spleens, livers and lungs (Additional
file 1: Figure S1C). Accurate weights for individual lymph
nodes were not recorded therefore cell/mg could not be
calculated. These data indicate that aging is associated
with an increase in the percentage of DCs in most tissues
except the spleen and lungs.
CD11c+ DC subsets are redistributed in elderly
murine tissues
The same tissues were analysed for conventional
CD4+CD8α−, CD4−CD8α+, CD4−CD8α− DC subsets
(Figure 2A) and CD11c+B220+GR1+ pDCs (Figure 2B).
CD4−CD8α− DCs were the dominating subpopulation
in young adult mesLNs, followed by CD4+CD8α− DCs,
with CD4−CD8α+ and pDCs being rarer subpopulations
(Figure 2C). Similar data were seen in supLNs and axil-
lary (ax) LNs (Figure 2E). pDC and CD4−CD8α+ DC
percentages significantly increased, whilst CD4+CD8α−
and CD4−CD8α− DCs significantly decreased in mesLNs
from elderly relative to young mice (Figure 2C). We ob-
served increased pDC and CD4−CD8α+ DC proportions
in most LNs of elderly mice, with the exception of pDCs
in supLNs which did not change (Figure 2E). Furthermore,
although the CD4−CD8α− subpopulation remained dom-
inant, pDCs and CD4−CD8α+ DCs represented a greater
fraction of total DCs in elderly-derived mesLNs.
CD4−CD8α− DCs were also the dominant DC subset in
young-derived spleens, followed by CD4+CD8α− DCs,tissues. Murine tissues were harvested, disaggregated into single cell
gated relative to the isotype control using flow cytometry (A). The
erly mice (B). Data is shown as individual values (dots) and mean ± SEM,
≤ 0.05; ** = p≤ 0.01; *** = p≤ 0.001; **** = p≤ 0.0001.
Figure 2 Redistribution of CD11c+ DC subsets in elderly-derived mesLNs and livers. CD4+CD8α−, CD4−CD8α+, CD4−CD8α− DCs (A) and
B220+GR1+ pDCs (B) were identified within gated CD11c+ cells. DC subset distribution is shown as a percentage of the CD11c+ cells in mesLN
(C) and liver (D); data is shown as individual values and mean ± SEM. * = p≤ 0.05; ** = p≤ 0.01; *** = p≤ 0.001; **** = p≤ 0.0001. The distribution
of CD11c+ DC subsets in the remaining tissues are shown as mean percentages of CD11c+ cells (E). Data in (C), (D) and (E) are pooled from 2
separate experiments, total n = 7 – 8 mice/group.
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creases in the proportions of splenic pDCs and CD4+CD8α−
DCs and a significant increase in CD4−CD8α− DCs with
aging (Figure 2E); age-related changes in pDCs and
CD4+CD8α− DCs were maintained when calculated as
cells/mg of tissue (Additional file 1: Figure S1D).
Liver DC subset distribution was similar to mesLNs in
young mice, with CD4−CD8α− DCs being the numerically
dominant population, followed by CD4+CD8α− DCs.
However, pDCs represented a greater proportion of
CD11c+ DCs, and CD4−CD8α+ DCs were the rarest subset
(Figure 2D). Similar to mesLNs, pDCs and CD4−CD8α+
DCs significantly increased and CD4−CD8α− DCssignificantly decreased in elderly-derived livers relative to
their younger counterparts (Figure 2D). Similar trends
were seen in the pDC and CD4−CD8α+ DC subsets when
expressed as cells/mg, although the differences did not
reach statistical significance (Additional file 1: Figure S1E).
These data show that pDCs and CD4−CD8α+ DCs in-
creased in elderly-derived livers and pDCs became the nu-
merically dominant population.
CD4−CD8α− DCs also dominated young adult lungs,
followed by CD4+CD8α− DCs, CD4−CD8α+ DCs and
pDCs (Figure 2E). Age-related changes in elderly-derived
lungs included significant increases in CD4−CD8α− DCs,
decreased CD4−CD8α+ DCs and no change in pDC
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changes were seen when expressed as cells/mg of tissue
(data not shown).
Overall, these data show that increasing age was asso-
ciated with a redistribution of DC subsets in secondary
lymphoid organs as well as in liver and lungs. There was an
increase in pDCs and CD4−CD8α+ DC proportions in livers
and most lymph nodes. In contrast, pDC numbers did not
change in lungs, and decreased in elderly-derived spleens.The steady state activation status of DC subsets changes
with increasing age
The aging process and/or age-related lipid accumulation
may impact on the activation status of DCs. Therefore ex-
pression of surface markers associated with Ag presentationFigure 3 pDC and CD4−CD8α+ DC activation status is influenced by a
by co-expression of CD40 (A and D), MHC-I (B and E) and MHC-II (C and
mean fluorescent intensities (MFIs) and mean ± SEM, total n = 7 – 8 mice/gand T lymphocyte stimulation (CD40, MHC class-I and
MHC class-II molecules) was examined.
We first examined the pDC subset. Relative to young
adult mice CD40 expression on pDCs significantly
decreased with age in spleens, axLNs and lungs, yet
significantly increased in livers (Figure 3A). MHC class-I
expression significantly increased on pDCs in elderly-
derived livers and showed an increasing trend in elderly-
derived lungs, but did not change in spleens, mesLNs,
supLNs and axLNs (Figure 3B). MHC class-II expression
significantly increased in elderly-derived supLNs and
lungs, showed an increasing trend in elderly-derived
mesLNs and did not change in elderly-derived spleens,
axLNs and livers (Figure 3C).
When examining CD4+CD8α− DCs, expression of
CD40 showed an increasing trend in elderly-derivedge. The activation status of pDCs and CD4−CD8α+ DCs was evaluated
F). Representative data from 1 of 2 experiments is shown as individual
roup. * = p≤ 0.05; ** = p≤ 0.01; *** = p ≤ 0.001; **** = p≤ 0.0001.
Figure 4 Neutral lipid content is influenced by age and DC
subpopulation in mesLNs and livers. The lipid content of DC
subpopulations from murine mesLNs (A) and livers (B) was evaluated
by flow cytometry following BODIPY staining. Representative data from
1 of 2 experiments is shown as individual MFIs and mean ± SEM, total
n = 7 – 8 mice/group. Significance was calculated using two-way
ANOVA. * = p≤ 0.05; ** = p≤ 0.01; *** = p≤ 0.001; **** = p≤ 0.0001.
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file 2: Figure S2A). MHC class-I expression on CD4+CD8α−
DCs did not change with age in any organ examined
(Additional file 2: Figure S2B) and MHC class-II expres-
sion on CD4+CD8α− DCs varied in the different tissues
however, no age-related changes were seen (Additional
file 2: Figure S2C).
CD40 expression significantly increased on CD4−CD8α+
DCs from elderly-derived livers and supLNs and sig-
nificantly decreased on CD4−CD8α+ DCs in spleens
(Figure 3D). MHC class-I expression on CD4−CD8α+ DCs
significantly increased in elderly-derived mesLNs and
livers and did not change in lungs, supLNs, axLNs
and spleens (Figure 3E). MHC class-II expression on
CD4−CD8α+ DCs displayed a significant increase in
elderly-derived livers and lungs and a significant decrease
in elderly supLNs (Figure 3F). No age-related changes in
MHC class-II expression on CD4−CD8α+ DCs were seen
in the other organs (Figure 3F).
CD40 expression on CD4−CD8α− DCs significantly
decreased in elderly-derived lungs and axLNs relative to
their younger counterparts; no changes were seen in the
other tissues (Additional file 2: Figure S2D). MHC class-I
expression on CD4−CD8α− DCs increased in elderly-
derived spleens, decreased in supLNs and did not change
in other tissues (Additional file 2: Figure S2E). Finally,
MHC class-II expression on CD4−CD8α− DCs did not
change with age in any organ examined (data not shown).
Taken together, these data indicate that there are com-
plex, organ-specific changes in DC activation status with
increasing age. CD4−CD8α+ DCs displayed organ-specific
CD40, MHC class-I and MHC class-II expression; e.g.
CD40 expression increased in elderly-derived supLNs and
livers, but decreased in spleens, whilst MHC class-I
expression increased in mesLNs and livers, but did not
change in other organs examined.
Age-related changes in pDC activation status were also
organ-specific. CD40 expression by pDCs decreased in
spleens, axLNs and lungs, but significantly increased in
livers. Conversely, pDC expression of MHC class-I in-
creased with age in liver, whilst MHC class-II expression
increased with age in supLNs and lungs.
Lipid content is influenced by age and DC subset
Until now, no studies had examined lipid accumulation
by tissue DC subsets in aging. Different sites such as the
mesLN and liver are exposed to higher levels of trigly-
ceride rich lipoproteins due to their proximity to the gut
and role in lipid metabolism respectively. Therefore, the
influence of anatomical location on neutral lipid content
in DC subsets in the aging context was examined using
BODIPY, a lipophilic fluorescent stain.
Our data show that regardless of age pDCs in all ana-
tomical locations contained the most lipid, followed byCD4−CD8α+ DCs, and that lipid content in these DCs in-
creased with age. For example, in young-derived mesLNs,
pDCs contained the most lipid, followed by CD4−CD8α+
DCs, CD4+CD8α− DCs and CD4−CD8α− DCs; lipid con-
tent increased with age in the total CD11c+ DC popula-
tion which was likely due to the significant increases in
pDC and CD4−CD8α+ DC lipid content (Figure 4A). Simi-
lar age-related increases in DC lipid content were seen in
(i) supLNs (Additional file 3: Figure S3A), with significant
increases in lipid content of pDCs and CD4−CD8α+ DCs
with age; (ii) axLNs in which elderly-derived pDC lipid con-
tent significantly increased (Additional file 3: Figure S3B);
and (iii) livers, again with significant increase in CD11c+
DC lipid content with age, correlating to increases in
pDC and CD4−CD8α+ DC lipid content (Figure 4B).
There were no significant age-related changes in lipid
content in the remaining CD4+CD8α− and CD4−CD8α−
subsets.
Spleens and lungs were different as whilst pDCs con-
tained high lipid levels, followed by CD4−CD8α+ DCs in
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in lipid levels were seen (data not shown). These data
show that pDCs and cross-presenting CD4−CD8α+ DCs
contain the most lipids in all young murine tissues exam-
ined. Furthermore, the lipid content of both these subsets
increased with age in livers and LNs, which may suggest
increased lipid uptake.
Scavenger receptor, LPL and VLDLr expression is
influenced by age and DC subset
We next asked how lipids might be taken up by DCs.
Lipoprotein specific receptors, such as LDLr [18] and
VLDLr [15], LPL [9] and the scavenger receptors low
density lipoprotein receptor-related protein 1 (LRP-1)
[10,14], CD36 [12] and CD68 [13] mediate the uptake of
modified and native lipoproteins by macrophages and may
also play a role in DC lipid accumulation [6]. Therefore,Figure 5 LPL, scavenger receptor and VLDLr expression is influenced
(E) expression on DC subsets was assessed by flow cytometry. Representat
mean ± SEM, total n = 7 – 8 mice/group. * = p≤ 0.05; ** = p≤ 0.01; *** = p≤we determined if DCs from different anatomical locations
differentially express LPL, LRP-1, CD36, CD68 and
VLDLr, and whether age influences their expression.
LPL, scavenger receptor and VLDLr expression levels
(measured using MFI) were low in all DC subsets in
young-derived mesLNs (Figures 5A to 5E). With aging,
LPL (Figure 5A) and CD36 expression (Figure 5B) in
mesLNs significantly increased in pDCs, CD4+CD8α− and
CD4−CD8α+ DCs; no changes were seen in CD4−CD8α−
DCs. In elderly-derived mesLNs, CD68 expression signifi-
cantly increased in CD4−CD8α+ and CD4−CD8α− DCs, with
a similar trend in pDCs, but no changes in CD4+CD8α−
DCs (Figure 5C). LRP-1 expression also significantly in-
creased in pDCs and CD4−CD8α+ DCs but not in other DC
subsets (Figure 5D). In contrast, VLDLr expression signifi-
cantly decreased in CD4−CD8α+ and CD4−CD8α− DCs and
did not change in the remaining DC subsets (Figure 5E).by age in mesLNs. LPL (A), CD36 (B), CD68 (C), LRP-1 (D) and VLDLr
ive data from 1 of 2 experiments is shown as individual MFIs and
0.001; **** = p≤ 0.0001.
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CD4−CD8α+ DCs in other lymph nodes were not sig-
nificant, however there were age-related increases for
CD36 in pDCs and CD4−CD8α+ DCs, and similarly for
CD68 in supLN pDCs and axLN CD4−CD8α+ DCs
(data not shown).
LPL expression in elderly-derived spleens significantly
increased in pDCs, CD4−CD8α+ and CD4−CD8α− DCs
(Additional file 4: Figure S4A). CD36 expression signifi-
cantly increased in CD4+CD8α− DCs, and did not change
in the other subsets (Additional file 4: Figure S4B).
CD68 expression significantly increased on pDCs and
CD4−CD8α+ DCs (Additional file 4: Figure S4C).
LRP-1 (Additional file 4: Figure S4D) and VLDLr
(Additional file 4: Figure S4E) expression significantly de-
creased in all DC subpopulations in elderly-derived spleens.Figure 6 LPL, scavenger receptor and VLDLr expression is influenced
(D) and VLDLr (E) expression on liver DC subsets was assessed by flow cyto
individual MFIs and mean ± SEM, total n = 7 – 8 mice/group. * = p≤ 0.05; *Expression levels of LPL (Figure 6A), CD36 (Figure 6B),
CD68 (Figure 6C), LRP-1 (Figure 6D) and VLDLr (Figure 6E)
significantly increased in pDCs and CD4−CD8α+ DCs in
elderly-derived livers; no changes in expression levels of these
receptors were seen in the remaining DC subsets.
In elderly-derived lungs, LPL (Additional file 5:
Figure S5A), LRP-1 (Additional file 5: Figure S5B)
and CD68 (Additional file 5: Figure S5C) expression
significantly increased on pDCs and CD4−CD8α+ DCs.
Conversely, whilst CD36 expression significantly decreased
on CD4+CD8α− and CD4−CD8α− DCs, it did not change on
pDCs or CD4−CD8α+ DCs (Additional file 5: Figure S5D),
and VLDLr expression in the latter significantly increased
with age (Additional file 5: Figure S5E).
Overall, the data show that tissue pDCs and CD4−CD8α+
DCs acquire lipids in numerous tissues during aging, whichby age and DC subset in livers. LPL (A), CD36 (B), CD68 (C), LRP-1
metry. Representative data from 1 of 2 experiments is shown as
* = p≤ 0.01; *** = p≤ 0.001; **** = p≤ 0.0001.
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pression, particularly in livers and mesLNs.
Discussion
There is limited evidence that DC biology may be altered
with aging. Furthermore studies on age-related changes to
DC numbers and activation status are conflicting. This is
particularly true for human studies of circulating DC sub-
sets; some have shown a significant decrease in circulating
pDC numbers with no change in myeloid DC numbers
[19-22], whilst others reported a decrease in myeloid DC
populations with no change in pDC numbers [23]. Simi-
larly, whilst several studies have shown that expression of
key surface molecules related to antigen presentation do
not vary due to age [24-26], others have described a sig-
nificant drop in HLA-DR expression on elderly-derived
DCs [27]. Several factors are known to influence DC func-
tion, and recently the influence of lipids and lipid accumu-
lation on DC biology and function in both healthy and
pathological contexts has become apparent. However, to
our knowledge, no studies have examined DC subset dis-
tribution, activation status, or lipid accumulation in the
context of healthy aging.
Our in vivo studies using mice show that DC subset
tissue distribution is altered with aging. We observed an
increase in the percentages of CD11c+ DCs in all tissues
except the lungs. Interestingly, this increase was not
universal across all DC subsets, but was attributable to
significant increases in pDCs and CD4−CD8α+ DCs in
most tissues. Plasmacytoid DCs and cross-presenting
CD4−CD8α+ DCs play key roles in anti-viral and anti-
tumour immunity [28]. Cross-presenting DCs are the
only DCs that can induce CD8+ T-cell mediated im-
mune responses following vaccination, viral challenge
or encounter with pathogenic self Ag. Furthermore, it
has recently been shown that in non-pathological con-
ditions pDCs and CD4−CD8α+ DCs may also play a
role in immune tolerance [28,29]. Previous studies
have reported that pDC numbers in human blood de-
crease with age [22,30]. Taken with data from this
study, we postulate that there is an age-related redis-
tribution of DC subsets, and that pDCs may accumu-
late in secondary lymphoid tissues and livers with
increasing age leaving lower numbers available for cir-
culation. Alterations in DC tissue distribution may
also be due to the age-related decreases in T- and
B- lymphocytes, which have been shown to result in a
decreased efficiency of immune responses [2]. Thus, we
postulate that as modulators of immune responses, DCs
in the elderly migrate to T- and B-cell rich sites such as
the LNs in an attempt to restore immune function
through increased lymphocyte stimulation.
Data from this study also suggests that DC activation sta-
tus in the absence of obvious pathology is influenced byage. Changes in activation status of pDCs were organ-
specific, indicating that the tissue microenvironment is a
major influencing factor in DC biology. Expression of
CD40 was decreased in spleens, axLNs and lungs, suggest-
ing a decreased capacity for T-cell licencing via CD40 in
these organs. However, T-cell licencing capacity may be in-
creased in elderly livers, due to the observed increase in
CD40 expression with age. There was also an age-related
increase in expression of MHC class-I and class-II mole-
cules, suggesting an increased capacity for Ag presentation.
Furthermore, activated pDCs are the primary producer of
type I interferons, which drive the production of other pro-
inflammatory cytokines, and the activation and recruit-
ment of leukocytes [31]. Changes in activation status of
conventional DC subsets were also organ-specific. For ex-
ample, CD40 expression by CD4−CD8α+ DCs increased in
elderly-derived supLNs and livers, but decreased in spleens.
Changes in MHC class-I and class-II expression also
showed organ-specific patterns. Although the exact pheno-
typic modifications were organ-specific, the result was an in-
creased steady-state activation status of CD4−CD8α+ DCs in
non-lymphoid organs. Activated CD4−CD8α+ DCs produce
large quantities of the pro-inflammatory cytokine IL-12,
which similarly drives lymphocyte activation and
recruitment during immune responses [32]. Whilst our data
suggests that elderly DCs may have improved antigen pres-
entation capacity (via increased expression of MHC mole-
cules) in some tissue sites, this contrasts with evidence that
T cell responses are decreased in elderly hosts [33,34]. This
may be explained by intrinsic defects in elderly T cells which
may render them unable to respond to stimulation by DCs
[33,34]. Reduced expression of co-stimulatory molecules on
elderly DCs, such as the reduction in CD40 expression that
we observed in some tissue sites, may also limit T cell re-
sponses in elderly hosts. Furthermore, increased expression
of inhibitory molecules, such as PD-L1, on elderly DCs (our
unpublished data and [35]) may also contribute to reduced
T cell responses in the elderly. Thus, the outcomes of age-
related changes in DC activation status are complex and
may depend on other factors, such as the tissue microenvir-
onment and age-related changes in other immune cells.
Ibrahim et al. demonstrated that the lipid content of
hepatic DCs was a determinant of their immunogenicity,
and that lipid-laden DCs produced higher levels of TNF-α
[36]. TNF-α is a powerful pro-inflammatory cytokine
which is associated with numerous pathologies [37,38].
Thus, increases in pDC and CD4−CD8α+ DC activation
may result in increased secretion of pro-inflammatory fac-
tors and the establishment of a pro-inflammatory micro-
environment. Polarizing DCs toward a pro-inflammatory
phenotype may alter the types of immune responses gen-
erated at different organ sites. For example, mesLNs and
livers are important sites for the development of oral tol-
erance [39], which relies on Ag presentation by pDCs
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liver pDCs, which may suggest increased immunogenicity,
as observed by others [36], possibly resulting in a break-
down of tolerance in these sites.
The establishment of an age-associated pro-inflammatory
microenvironment may contribute to chronic low-grade ac-
tivation of DCs, which could promote and/or facilitate the
onset of pathologies associated with aging such as auto-
immunity or cancer [8]. Furthermore, the development of a
semi-mature phenotype by pDCs and CD4−CD8α+ DCs
may inhibit the development of adaptive immune responses
against viral infections and tumours, thus contributing to
impaired clearance of viral infections, a reduced efficiency
of vaccinations, and increased incidence of cancer in the
elderly. Furthermore, studies of anti-cancer immunity have
shown that in the presence of tumour cells and tumour-
derived factors, DCs readily accumulate lipids resulting in a
decreased ability to stimulate T-cell immune responses [6].
Despite the associations seen between lipid content and
altered function, no studies have yet established how DCs
accumulate lipid. Lipid accumulation in macrophages has
been well studied and numerous receptors and lipid trans-
porters have been identified as significant contributors
including lipoprotein specific receptors (LDLr and
VLDLr), scavenger receptors (Msr-1, CD36, CD68) and
LPL [6,9-14,36,41]. The latter is a serine hydrolase that re-
leases free fatty acids from circulating triglyceride-rich
lipoproteins, but it can also facilitate uptake of triglyceride-
rich lipoproteins by lipoprotein receptors, including LRP-1
[42] and VLDLr [43]. There are few studies on DCs, but
Herber et al. [6] found a role for Msr-1 (CD204), and Ibra-
him et al., who studied liver DCs, found a role for Msr-1,
CD68 and LPL [36]. In our study, the increased lipid con-
tent of DCs from aged mice was consistently accompanied
by increased LPL. A number of receptors can work in con-
cert with LPL to cause lipid accumulation, e.g. by mediat-
ing uptake of the fatty acids released by LPL (e.g. CD36) or
by increased lipoprotein uptake through formation of a
complex with lipoprotein receptors (e.g. LRP-1 or VLDLr);
in our study, liver DCs of aged mice had increases in both
CD36 and LRP-1, as well as VLDLr and CD68. In other tis-
sues, the increased DC lipid and LPL expression in pDCs
and CD4−CD8α+ DCs was also associated with an in-
creased expression of receptors, but the type and number
of receptors involved varied. Lung and mesLN-derived
DCs showed upregulation of some but not all scavenger re-
ceptors, whereas for spleen, whilst CD68 was increased,
LRP-1 and VLDLr expression decreased.
The elevation in DC lipid levels may be explained by an
increase in LPL, the lipoprotein receptors or a combin-
ation of both. The fact that LPL was so consistently
elevated with age suggests an important role for this par-
ticular enzyme. Moreover, our observation that different
receptors may be involved at different tissue sites is notsurprising since DCs in these different sites may be
exposed to different milieu. For example, the liver plays a
major role in lipid metabolism, and is a major site of lipo-
protein synthesis, resulting in exposure of DCs to higher
concentrations of lipoproteins, particularly triglyceride-
rich lipoproteins. Intestinally derived triglyceride-rich lipo-
proteins reach circulation via mesenteric lymph and the
thoracic duct; as such mesLNs may also be exposed to
high concentrations of these lipoproteins, and of the
lymph nodes examined, mesLNs showed more marked
age-related changes in lipid accumulation, LPL and ex-
pression of receptors potentially involved in lipid uptake.
Lipid levels including plasma cholesterol and triglycerides
increase with age in humans and animal models [44-46].
However, whilst exposure to lipids may result in changes
in DC phenotype and function, other environment-
derived factors, particularly in the context of aging, also
likely modulate the expression of these molecules. Such
factors may include age-related increases in modified lipo-
protein particles such as oxidised lipoproteins which have
been shown to stimulate the increased expression of scav-
enger receptors in macrophages [47]. Interferon gamma
has been shown to increase uptake of triglyceride-rich
lipoproteins in macrophages via an LPL dependent mech-
anism [41], and an age dependent inflammatory process
may thus have similar effects on DCs.
Conclusions
Aging is accompanied by increases in tissue pDCs and
CD4−CD8α+ DCs in association with increasing DC lipid
accumulation and partial activation. Interestingly, these
effects were most distinct in tissues which may be
exposed to elevated levels of lipoproteins such as the
mesLNs and liver, suggesting that the immunomodula-
tory effects of lipids are most at play in these locations.
Increased activation of pDCs and CD4−CD8α+ DCs has
been associated with the increased production of pro-
inflammatory factors such as type-I interferons, which may
contribute to the establishment of a pro-inflammatory
microenvironment. Such pro-inflammatory environments
have been implicated in promoting the development and
maintenance of cancer and autoimmunity, pathologies
common in elderly hosts. Furthermore lipid-mediated DC
dysfunction, characterised by a decreased capacity to initi-
ate T-cell mediated immune responses, may also result in a
decreased capacity to clear viral pathogens, resulting in an
increased prevalence of infection and decreased efficiency
of vaccinations in the elderly.
Methods
Mice
Young adult (6–8 weeks) and elderly (22–24 months)
female C57BL/6J mice obtained from the Animal
Resources Centre (Perth, Western Australia) were housed
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animal facility. Animal experiments were performed as
per Curtin University Animal Ethics Committee (AEC)
approval number AEC-2012-21.
Murine tissue collection and processing
Secondary lymphoid organs (spleens, mesenteric lymph
nodes, superficial cervical lymph nodes and axillary lymph
nodes) were processed into single cell suspensions be-
tween two frosted glass slides. Livers and lungs were sliced
into 0.5 mm3 sections then digested for 90 mins at 37°C
in type 4 collagenase (1 mg/mL; Sigma-Aldrich, Missouri,
USA) and bovine pancreatic DNase (0.1 mg/mL, Sigma-
Aldrich) in FACS buffer consisting of PBS with 2% fetal
calf serum (FCS; ThermoScientific, Massachusetts, USA)
and 1% bovine serum albumin (BSA; Sigma-Aldrich).
Samples were then triturated for 5 mins, filtered and incu-
bated at 4°C for 10 mins in FACS buffer containing 20%
FCS to aid cell recovery.
Flow cytometry: phenotyping, lipid quantification and
receptor expression
Murine DCs were surface stained for 30 mins in the dark at
4°C with fluorescently labelled antibodies against CD11c
(clone N418, BD), CD4 (clone RM4-5, BD), CD8α (clone
53–6.7, BD), GR1 (clone RB6.8C5, BD), B220 (clone
RA3.6B2, BD), CD40 (Biolegend, California, USA), MHC
class-I (Biolegend) and MHC class-II (Biolegend). For intra-
cellular lipid quantification, cells were incubated for 15
mins at 4°C in the dark with BODIPY 493/503 (Invitrogen).
For staining molecules associated with lipid uptake, cells
were fixed in 1% paraformaldehyde (Sigma-Aldrich) and
permeabilised with 0.1% saponin (Sigma-Aldrich). Cells
were incubated with fluorescently labelled anti-CD36
(Biolegend), anti-CD68 (Biolegend), LRP-1 (Santa Cruz,
California, USA), LPL (Abcam, Cambridge, UK) and
VLDLr (Abcam) in the dark for 30 mins at 4°C. Before
staining, mouse IgG1 antibodies (LPL and VLDLr) were
directly conjugated to zenon reagents (Invitrogen) as per
manufacturer’s instructions. Following LRP-1 staining,
cells were sequentially incubated with anti-goat biotin
(Dako, California, USA) and streptavidin-V500 (BD) in
the dark for 30 mins at 4°C.
Following staining, samples were washed twice and re-
suspended in FACS buffer for acquisition on a FACSCanto
II (BD) followed by analysis using FlowJo V10 software
(Treestar, Oregon, USA). Isotype-matched antibodies were
used as controls.
Data analysis
Statistical significance was calculated using non-
parametric Mann–Whitney Student’s t-test, using Graph-
Pad PRISM 5 (GraphPad Software Inc, California, USA).
P-values < 0.05 were considered statistically significant.Additional files
Additional file 1: Figure S1. Aging is associated with increased body
and organ weight and altered DC tissue distribution. Body (A) and organ
weight of young- and elderly-derived spleens, livers and lungs (B). DCs
were identified as per Figure 1 and expressed as CD11c+ cells/mg of
tissue (C); data shown as mean values ± SEM. DC subset distribution is
shown as cells/mg of tissue in spleens (D) and liver (E); data shown as
individual values and mean ± SEM. All data is pooled from 2 separate
experiments, total n = 7 – 8 mice/group. * p ≤ 0.05; ** = p ≤ 0.01;
*** = p ≤ 0.001; **** = p≤ 0.0001.
Additional file 2: Figure S2. DC activation status is influenced by age.
The activation status of CD4+CD8α− DCs was evaluated by co-expression
of CD40 (A), MHC-I (B) and MHC-II (C). Expression of CD40 (D) and MHC-
I (E) was also examined on CD4−CD8α− DCs. Representative data from 1
of 2 experiments is shown as individual mean fluorescent intensities
(MFIs) and mean ± SEM (total n = 7–8 mice/group). * = p ≤ 0.05; ** = p ≤
0.01; *** = p ≤ 0.001; **** = p ≤ 0.0001.
Additional file 3: Figure S3. Lipid content is influenced by age and
anatomical location. The lipid content of DC subsets from supLNs (A)
and axLNs (B) was evaluated by flow cytometry following BODIPY
staining. Representative data from 1 of 2 experiments is shown as
individual MFIs and mean ± SEM (total n = 7 – 8 mice/group). * = p ≤ 0.05;
** = p ≤ 0.01; *** = p ≤ 0.001; **** = p ≤ 0.0001.
Additional file 4: Figure S4. LPL, scavenger receptor and VLDLr
expression on DC subsets is influenced by age in spleens. LPL (A), CD36
(B), CD68 (C), LRP-1 (D) and VLDLr (E) expression on DC subsets was
assessed by flow cytometry. Representative data from 1 of 2 experiments
is shown as individual MFIs and mean ± SEM (total n = 7–8 mice/group).
* = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001; **** = p ≤ 0.0001.
Additional file 5: Figure S5. LPL, scavenger receptor and VLDLr
expression on DC subsets is influenced by age in lungs. LPL (A), LRP-1
(B), CD68 (C), CD36 (D) and VLDLr (E) expression on DC subsets was
assessed by flow cytometry. Representative data from 1 of 2 experiments
is shown as individual MFIs and mean ± SEM (total n = 7–8 mice/group).
* = p≤ 0.05; ** = p≤ 0.01; *** = p≤ 0.001; **** = p≤ 0.0001.
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